Vesalius Longevity Labs Inc. has raised $6.5M to build out its platform connecting licensed prescribers with participating pharmacies for patient-specific peptide prescriptions. The company is trying to close the gap between longevity science and clinical practice, offering prescribers access to peptide products manufactured in the United States with accompanying quality documentation.








